SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-013595
Filing Date
2022-03-18
Accepted
2022-03-18 16:23:08
Documents
13
Period of Report
2022-03-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT FILING ea157100-8k_enzo.htm   iXBRL 8-K 24492
2 AMENDMENT NO. 2 TO AMENDED AND RESTATED BY-LAWS OF ENZO BIOCHEM, INC., EFFECTIVE ea157100ex3-1_enzo.htm EX-3.1 2325
  Complete submission text file 0001213900-22-013595.txt   200022

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enz-20220311.xsd EX-101.SCH 3039
4 XBRL LABEL FILE enz-20220311_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE enz-20220311_pre.xml EX-101.PRE 22600
7 EXTRACTED XBRL INSTANCE DOCUMENT ea157100-8k_enzo_htm.xml XML 3582
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 22752840
SIC: 8071 Services-Medical Laboratories